FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc., under NDA 021259.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE)